Med-Aesthetic Solutions Names Greg Stevenson Regional Sales Manager

CARDIFF-BY-THE-SEA, CA (March 27, 2008)—Med-Aesthetic Solutions, Inc., (MAS) a global provider of practice building solutions and aesthetic technologies, announced today that Greg Stevenson has been appointed Regional Manager for the Northwest and Rocky Mountain States.

In his new role, Stevenson will be responsible for driving regional sales of the multi-part, Med-Aesthetic Solutions strategic practice building services, which provide physicians with tools to optimize opportunities in their aesthetic medical practices. He will further expand sales of the Company’s product portfolio, which includes iPulse™ Intense Pulsed Light Systems, Salt-A-Peel™ MacroDermabrasion Therapy and the Mastique Light™ Skin Rejuvenation System.

“Greg is very results-oriented and brings a thorough understanding of aesthetic sales and marketing to the MAS team,” said Allan Danto, President and COO. “As an experienced sales professional, he has achieved the highest levels of recognition for meeting and exceeding sales goals.”

Before joining MAS, Stevenson held sales management positions at leading healthcare companies such as IRIDEX, the Aesthetic Laser Division of Laserscope, HGM Laser Systems and Medical Alliance, Inc. He earned a bachelor’s degree in education from Weber State University in Ogden, UT.

Med-Aesthetic Solutions, Inc is headquartered in Cardiff-by-the-Sea, Calif., with an East Coast office in Danvers, Mass., and international offices in London and Sydney, Australia. Warehousing, distribution and customer care is based in Albuquerque, N.M.

Med-Aesthetic Solutions, Inc.
760.942.8815
www.medaestheticsolutions.com

Source: MSA

Ipsen and Medicis Announce Submission of Reloxin BLA in Aesthetics to the FDA

PARIS and SCOTTSDALE, Ariz., (PRIME NEWSWIRE) — Medicis (NYSE:MRX) and Ipsen (Euronext:IPN) today announced that Ipsen has submitted a Biologics License Application (”BLA”) for the botulinum toxin type A, Reloxin(R) (Note 1), in aesthetic indications (glabellar lines) to the U.S. Food and Drug Administration’s (”FDA”) Division of Dermatology and Dental Products, within the Center for Drug Evaluation and Research. This BLA submission by Ipsen is intended to address the concerns cited by the FDA when it declined to file the Reloxin(R) BLA in January 2008, which Medicis had submitted in late 2007. Standard response timeframe from the FDA is expected approximately 10 months following receipt of the Reloxin(R) submission. Subject to approval of the BLA by the FDA, Medicis intends to commercialize Reloxin(R) in the U.S. in accordance with the long-standing arrangement between Medicis and Ipsen. Changes from the original BLA submission relate primarily to sponsorship and ownership of the filing. The substantive elements of the original submission remain unchanged.

Jean-Luc Belingard, Chairman and Chief Executive Officer of Ipsen, said: “We are pleased to have responded to the administrative issues raised by the FDA in coordination with Medicis in a timely and efficient manner. Together with Medicis, we look forward to working diligently with the FDA to obtain a successful marketing approval. Given Ipsen’s botulinum toxin positive track record on a global basis, we look forward to entering the North American market following FDA approval of Reloxin(R).”

“We are pleased to announce this submission of the BLA for Reloxin(R) in aesthetics with FDA,” said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. “Both the Ipsen and Medicis teams have worked diligently with FDA to determine the best solution for submitting Reloxin(R) in aesthetics. We thank everyone involved, and extend our appreciation to FDA for its willingness to work with us on a resolution in a timely fashion. We continue to believe the Reloxin(R) BLA is strong, and anticipate entering in the growing, multi-million dollar aesthetic botulinum toxin market in the U.S. upon FDA approval.”

In March 2006, Ipsen granted Medicis the rights to develop, distribute and commercialize Ipsen’s botulinum toxin product in the United States, Canada and Japan for aesthetic use by physicians. Upon FDA’s acceptance of the Reloxin(R) submission, Medicis will pay Ipsen approximately $25 million in accordance with the agreement between the parties.

According to the American Society for Aesthetic Plastic Surgery, injections of botulinum toxin type A were the number one non-surgical procedure in 2006, with over 3 million total procedures. Current growth estimates in botulinum toxin type A in dollars are estimated to be in excess of 20 percent over the prior year. This translates into a retail U.S. aesthetic market of approximately $300 million-$400 million (Note 2).

About Ipsen’s Botulinum Toxin Type A
As of October 2007, Ipsen’s botulinum toxin type A is approved for aesthetic indications in 21 countries: Argentina, Australia, Belarus, Brazil, Columbia, Ecuador, Egypt, Germany, Honduras, Israel, Kazakhstan, Mexico, Moldova, New Zealand, Philippines, Slovak Republic, Ukraine, Uruguay, Venezuela, Vietnam, and Russia (in Russia, it is the first botulinum toxin type A approved in this field). Ipsen is also pursuing regulatory approval for medical indications for the product in certain additional key international markets.
Dysport(R) is a neuromuscular blocking toxin which acts to block acetylcholine release, hence reducing muscular spasm, and was initially developed for the treatment of motor disorders and various forms of muscular spasticity, including cervical dystonia (a chronic condition in which the neck is twisted or deviated), spasticity of the lower limbs (heal) in children with cerebral palsy, blepharospasm (involuntary eye closure) and hemifacial spasm. It was later developed for the treatment of a wide variety of neuromuscular disorders and aesthetic medicine. Dysport(R) was originally launched in the United Kingdom in 1991 and has marketing authorisations in over 70 countries (at 31 December 2006). Ipsen has just recently filed a BLA for Dysport(R) in cervical dystonia to the FDA.

Medicis
www.medicis.com

Ipsen
www.ipsen.com

Source: Medicis

Luxury SpaFinder Magazine Becomes Luxury SpaFinder Interactive - Expands Global Reach to Six Languages

SpaFinder, Inc., the largest spa media company, announced today that Luxury SpaFinder Magazine will become Luxury SpaFinder Interactive, replacing the print magazine effective with the July edition. Luxury SpaFinder Interactive will be published monthly in six languages and will immediately expand the magazine’s global circulation from 200,000 to over one half million spa lifestyle enthusiasts. The launch of the interactive publication also underscores the company’s commitment to green initiatives.

Melisse Gelula, spa beauty editor of Luxury SpaFinder and former travel editor for Fodor’s Travel Publications, has been named editor in chief of Luxury SpaFinder In-teractive. Sarah Day, who was previously the print magazine’s production director, will serve as vice president of SpaFinder’s Global Publishing Group and will oversee the new interactive publication as well as the company’s worldwide spa directory, Global SpaFinder, which is the largest printed directory of its kind. Sue Llewellyn, who was art director of Luxury SpaFinder, will continue to oversee art direction and design of Luxury SpaFinder Interactive publication in her new position as Director of Global Publishing.

Luxury SpaFinder Interactive will be published in Japanese, French, German, Italian and Spanish, as well as English, and will be available on SpaFinder’s network of global SpaFinder websites, increasing potential readership to an additional six mil-lion consumers annually. SpaFinder owns and operates the leading spa lifestyle and wellness website, SpaFinder.com, with additional Internet domains in France, Italy, Germany, Spain and Japan. The company’s worldwide spa directory, Global SpaFinder, is a yearly print publication for consumers and travel agents.

Luxury SpaFinder Interactive expands our reach and presence in Europe, Asia, South America, and beyond,” said Pete Ellis, Chairman & CEO of SpaFinder. “It’s a big plus for our advertisers as we tap into enormous demand among Gen-X and Gen-Y consumers for spa and wellness information and the expansion of the spa market worldwide. Spa-goers are truly global and online, and that’s where they are going to be in greater numbers.”
Ellis anticipates that the circulation of Luxury SpaFinder Interactive will reach in ex-cess of one million consumers with each monthly issue, based on new website and company offerings that will be announced in the next 60 days. The publication will combine the attributes of a glossy print magazine and online media, offering luxury spa travel, wellness and lifestyle content in an interactive format that will include search capabilities.

According to SpaFinder data, annual revenues for the global spa industry are ap-proximately $45 billion, roughly three times as large as the $15 billion+ U.S. spa industry. “Luxury spas and luxury consumers are an increasingly global phenomenon,” adds Ellis. “And it’s no longer just Americans traveling to international spa destinations; it’s Australians going to spas in Asia, Asians going to spas in the Middle East, Europeans traveling to North America, etcetera. By publishing Luxury SpaFinder in a global medium, we can promote the spa lifestyle and spa vacations to consumers worldwide.”

About SpaFinder, Inc.
The world’s largest spa media, marketing and gifting company, SpaFinder, Inc. connects millions of wellness-focused consumers with thousands of spas worldwide. SpaFinder’s me-dia properties include the award-winning Spafinder.com, Luxury SpaFinder Interactive and the worldwide spa directory, Global SpaFinder. Spa Finder Gift Certificates and its new gift division, Spa & Salon Wish, offer spa gift certificates and cards that are redeemable at a combined network of over 5,000+ spas and salons worldwide and are available at thou-sands of retail outlets. The company’s software division innovates new solutions to help spas build and streamline their businesses, including the popular SpaBooker online booking system. SpaFinder Europe and SpaFinder Japan offer regional spa marketing and gifting programs, including localized, native-language websites. Founded in 1986, the privately held company is headquartered in Manhattan.

SpaFinder
www.spafinder.com

Source: SpaFinder

Frownies Facelift in a Bag- A Great Alternative to BOTOX® or Fillers

BOTOX®, surgery and lasers, oh my! These days, more and more women are subjecting themselves to procedures that have more in common with medieval torture devices than relaxing spas. While the popular “gift of beauty” trend always carries a thoughtful sentiment, technology has taken the popular phrase “beauty is pain” to a whole new level. This Mother’s Day, instead of gifting a well-deserving mom a service requiring recovery time, give her the gift of smooth, beautiful skin courtesy of Frownies!

Frownies, the legendary anti-aging company that introduced the world to Frownies Facial Pads, has created a gift set of their favorite products guaranteed to give moms young, healthy, and most importantly, natural looking skin. Frownies Facelift in a Bag is a practical, easy-to-maintain system designed to revamp tired-looking skin with the proven power of Frownies Facial Pads and Frownies newest creation: Immune Perféct Wrinkle Cream, a revolutionary new skincare product containing biologically active antioxidants, natural extracts and hydrators. In as little as 14 days moms will see dramatic results without spending thousands of dollars on doctor’s appointments!

NEW! Face Lift in a Bag™
Facelift in a Bag is the perfect introductory system meant to create a skincare routine for men and women suffering from aging skin. It contains Frownies’ famous Facial Pads to reduce wrinkles in the forehead, between the eyebrows, and in the corners of the eyes and mouth without injections or surgery. Facelift in a Bag also contains the popular Frownies skincare line: Frownies pH Balancing Complexion Wash, to deeply cleanse and balance the skin, and Frownies Rose Water Hydrator Spray, for use with Frownies Facial Pads for maximum wrinkle reduction. Lastly, Facelift in a Bag offers Frownies’ most powerful skincare product yet: Immune Perféct Wrinkle Cream, an active product delivery system that helps fight the oxidation caused by UV rays and environmental pollutants. Used together, Facelift in a Bag can produce visible results in as little at 14 days. Price: $99.95

Frownies Facial Pads
Individual wrinkle-reduction pads made for the forehead, between the eyebrows, corners of the mouth and eyes. Frownies Facial Pads are made from natural, skin-friendly materials. Once applied, they gently re-educate the underlying muscles to assume their correct, relaxed and natural appearance. Frownies allow even deep expression lines to heal, leaving younger, relaxed-looking skin. Retail Price: $19.95 each

Frownies Rose Water Hydrator Spray
Frownies Hydrator Spray is used to activate the adhesive side of Frownies Facial Pads. It provides a sterile, bacteria-free addition of anti-oxidants to the facial pads and can also be used to set makeup or as a refreshing pick up throughout the day, especially during air travel. Frownies Hydrator Spray contains glycerin, hyaluronic acid and sodium PCA, which are proven high quality natural humectants and plumpers, as well as rose water, for toning. Retail Price: $10.95

Frownies pH Balancing Complexion Wash
Frownies pH Balancing Complexion Wash is a concentrated soap-free glycolic wash that deeply cleans the skin of imbedded oil, wax and trapped pollution build-up. Gentle even for sensitive skin, yet powerful enough for chronic oily and blemished skin, Frownies pH Balancing Complexion Wash contains the freshness of lavender essential oil and the cleaning power of soapwort and soap yucca to detoxify, balance, and clean the skin’s surface without soap and detergent dryness. Retail Price: $18.95

Frownies Immune Perféct Wrinkle Cream
Frownies Immune Perféct Wrinkle Cream is an active delivery system containing antioxidants to help protect, renew and regenerate damaged cells, wrinkling and premature aging of the skin. Immune Perféct fulfills the skin’s need for hydration at a cellular level. Immune Perféct liquefies on contact with the skin, allowing instant activation with the cellular layers – which helps firm and tone the eyelids and the jaw line. Immune Perféct helps correct the damage caused by UV rays, color cosmetics, and harsh chemicals while helping rebuild and prevent the conditions that cause wrinkling and further cellular damage. Immune Perféct reduces skin irritation and inflammation, helping to regulate skin tone and texture. Retail Price: $59

About Frownies
Frownies was created in 1889 after Margaret Kroesen discovered that her daughter Alice, a concert pianist, had developed unsightly wrinkles and frown lines. With a desire to maintain her youthful beauty and stage presence, Mrs. Kroesen created Wrinkle Eradicators (as they were first called) by employing the basic principle of fitness to the muscles of the face. After using her mother’s amazing invention, Alice was a living testimony, and it became clear that women and men everywhere could benefit from these Wrinkle Eradicators.

Several years later, Mrs. Kroesen’s joined B & P (Beauty and Personality) Company as Managing Director. At the time, B & P specialized in barber supplies. Mrs. Kroesen eventually became the owner of B & P, and gradually dropped the barber supplies, and offered only her Wrinkle Eradicators and skin treatments. A few small ads were placed to help get the word out about her remarkable invention, and these soon paid off in increased sales. Alice Laumer, Mrs. Kroesen’s daughter, joined the business to help with the growing sales. After Alice’s death, Mrs. Kroesen remained at the helm of the company until her own passing in 1962. Following her mother and grandmother in business, Margaret Wright (named after her grandmother) redesigned and updated the packaging for Frownies, never altering the formula which had proven so effective.

Now, more than a century since they were created, Mrs. Wright still oversees the operations of the company, but her daughter-in-law, Kathy Wright, is now taking her turn as the fourth generation woman helping preserve the faces of women and men everywhere. Kathy Wright is in her fifth year as CEO/General Manager of B & P Company. Again, the Frownies box has changed, but the 115 year-old formula remains intact, and Kathy brings a bright new direction to the company.

Frownies
800.648.6891
www.frownies.com

Source: Frownies

New Day Spa Association Advisory Board 2008 to 2009 Committees & Honors Announced

Union City, NJ Hannelore Leavy, President and Executive Director of the Day Spa Association and the International Medical Spa Association announces the new 2008 to 2009 Day Spa Association Advisory Board. The DSA Advisory Board has been streamlined and simplified to be more efficient. All ‘Members At Large’ are now encouraged to volunteer and to actively participate on committees.

Hannelore Leavy notes, “With great pride, I am pleased to announce that Rosemary Weiner, owner of The Brass Rose Day Spa & Salon in Blairstown, NJ has graciously agreed to maintain the reigns as chairperson of the DSA Advisory Board for another year.” Before entering the spa industry, Rosemary Weiner had a distinguished career as a nurse and as the Vice President of operations and a partner in a Fortune 500 national healthcare cost containment company. She uses her medical background and business acumen in developing the policies, procedures, treatments, culture, and philosophy that are the cornerstone of The Brass Rose and which have become a model for the day spa industry.”

Skip Williams, Vice President of Spa Operations Consulting services, the author of “The Reluctant Spa Director and The Mission Dream” and a previous recipient of the DSA ‘Spa Person Of The Year Award’, remains chairperson of the Day Spa Association Education and Trade Show Committee. Monique Iacobacci remains Chairperson of the Charity Events Committee. Her latest endeavor is Co-Founder and Executive Director of SPAcare, the industry’s first organized non-profit charitable resource. Her goal is to unify and support the Philanthropic efforts of the Spa, Wellness and Medical communities. The DSA Membership Committee will be chaired by Ana Loiselle-Donahue, of the SECRET Salon & Spa By Design. Donahue is a consultant specializing in helping day spa businesses flourish through creative solutions, including brand development, strategic financial planning and employee training.

Larry Oskin, president of Marketing Solutions headquartered in Fairfax, VA will be the new chairperson of the DSA PR & Media Relations Committee. Marketing Solutions remains a full service marketing, advertising and PR agency specializing in the salon, day spa and medical spa industries. The DSA Industry Research Committee will be chaired by Erika Mangrum of the Iatra Day Spa, which has four successful locations in Raleigh, NC. Erika previously formed Corporate Health Fairs, a consortium of Triangle female business owners, which provides health fairs for regional businesses free of charge. The DSA Legislative Affairs Committee is now chaired by Ruth Nuckols Cox of the Sharman, TX based Bella Fontana Spa. Cox has a diverse background with expertise in day spa operations, finance, business process development and information technology.

Mike Carter is the new chairperson of The Corporate Alliances & Sponsorships Committee. Carter is president and CEO of the Athena Health Club & Day Spa. Carter also serves as president of Athena Health Sphere, an injury prevention and wellness company as well as a partner in the Pinnacle Construction Company in Tennessee. Eric Light continues to be the chairperson of the DSA International Chapters, while maintaining his position as president of The Strawberry Hill Group, supervising the North and Latin American markets. Light has visited almost 90 different countries worldwide, while consulting with day spa and wellness industry projects. Dr. Stephen Schleicher, F.A.C.S. is the Day Spa Association’s Medical Advisor. Schleicher is founder and director of the DermDX Centers for Dermatology in Northeastern Pennsylvania. Dr. Schleicher is also a clinical instructor of dermatology at Kings College and Arcadia University.

Day Spa Association Membership: Membership includes many special privileges with inclusion in The Annual Day Spa / Medical Spa Directory, a listing on the www.DaySpaAssociation.com website, a membership certificate, seasonal newsletters, email blasts, invitations to advanced educational seminars, free magazine subscriptions to many select industry and consumer publications, a group health insurance program, special credit card processing rates and a variety of discounts with many professional services within the spa and beauty industries. The Day Spa Association has also recently launched a new Day Spa Accreditation Program and invites the day spa industry to join into this consumer awareness program that will properly distinguish accredited day spas from the rest. International Chapters are located in Europe, Latin America, Asia and the Caribbean.

It Is Time To Get Involved! Now is the time to capture your part in the fastest growing segment of the professional beauty and wellness industries, by learning how to stay ahead of the competition.

Day Spa Association
201.865.2065
info@DaySpaAssociation.com
www.DaySpaAssociation.com

Source: Day Spa Association

Institute for Aesthetic Medicine Announces New Laser Training Physician and Nurse Networks

Networks provide ‘in-office’ CME-based laser training options to plastic surgery and dermatology professionals

Miami, Florida - The Institute for Aesthetic Medicine (IAM) announced today the creation of a nationwide laser-training physician and nurse network for plastic surgery and dermatology professionals. Laser practitioners unable to attend one of IAM’s clinical, hands-on certification classes can now have personalized clinical training in a single visit.
“The physician and nurse networks are unique as they bring office-side laser training to busy aesthetic laser practitioners,” said Amy Pope, director of the IAM Nurse Network. “Think of it as ‘concierge’ laser training at your door.”

The CME-based classes are designed for users of all skill levels—both physician and staff, new or veteran. The instruction takes the attendee from basic concepts of light and clinical application through a clear path to the most current thinking on how, why, and when aesthetic procedures are performed. Participants now have a single laser training resource dedicated to improving patient safety and minimizing professional liability.

“Receiving aesthetic hands-on laser training in a hotel setting is not conducive to a real-world environment and potentially risky,” said Michael Gold, M.D., chief medical officer and co-founder of The Institute for Aesthetic Medicine. “Only training in a well-defined clinical setting can deliver the most professional, efficacious skills.”

Certification classes will be held in Newport Beach, CA, March 29-30 (Sciton-sponsored); St. Louis, MO, April 5-6, and Chicago, IL, April 26-27. Participants receive up to 24 CME contact hours depending on course selection. For some training venues, IAM offers a third day of training and certification for Medical Laser Safety Officers (MLSOs). Personalized, in-office physician and nurse network training is arranged by directly contacting IAM.

About Institute for Aesthetic Medicine, Inc. (IAM)
IAM is a Miami-based corporation organized in 2007. Co-founders Cindy L. Vandruff and Michael H. Gold, M.D. are leading experts in the aesthetic medical industry. The main focus of the company is education, hands-on training and safety through an extensive network of partners and affiliates. For more information about IAM or CME training classes contact Gregg Wright, president and general manager, gregg.wright@iameducated.com

Institute for Aesthetic Medicine, Inc. (IAM)
800.436.9311
www.IAMeducated.com

Source: IAM

Palomar and P&G Enter New License Agreement

Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced that it has entered into a non-exclusive License Agreement with The Procter & Gamble Company (NYSE: PG) to exploit home-use light-based hair removal devices for women. This new agreement replaces the Development and License Agreement entered into by Palomar and The Gillette Company, (a wholly owned subsidiary of P&G) on February 14, 2003, as Amended and Restated on February 14, 2007, and as further amended thereafter. Under this new agreement, P&G retains a non-exclusive license to Palomar’s broad patent portfolio as well as a non- exclusive license to the extensive technology developed by Palomar before and during the five year term of the prior agreement. Prior to launching a commercial product, P&G will pay Palomar $1.25 million per calendar quarter. Following commercial launch P&G will pay Palomar per product sales under a confidential financial arrangement which addresses both the patents and technology which are licensed.

During the term of the prior Development and License Agreement, a home- use, light-based hair removal device for women was developed by Palomar together with Gillette. It is the first light-based aesthetic device to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA). OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. Designed specifically for use in the home and based on over a decade of research, this consumer device represents a major breakthrough in the aesthetic device industry.

In order to achieve FDA clearance, numerous clinical studies with over 600 subjects and thousands of treatments were conducted. These studies demonstrated that, when used as directed, the light-based device created under this agreement delivers comfortable, effective, skin-safe hair removal.

Stephanie Connaughton, Marketing Director, Global Grooming, said: “We are pleased that we were able to find a win-win outcome that enables continued work on this promising technology and increases the likelihood of commercial success.”

Commenting on this development, Palomar Chief Executive Officer Joseph P. Caruso said, “We strongly believe that we have developed game changing technology, and we look forward to seeing P&G’s products on the market. Over the past five years, Palomar and Gillette worked together to advance the technology and we have made tremendous progress in moving closer to penetrating the mass consumer market. Our biggest single achievement together has been penetrating the regulatory barrier to gain FDA approval of the first laser device for the home market.”

For more information, please see the non-exclusive License Agreement filed as Exhibit 10.1 to a Current Report on Form 8-K filed today, the Amended and Restated Development and License Agreement and Amendment #1 to the Amended and Restated Development and License Agreement filed as Exhibits 10.1 and 10.2 to a Current Report on Form 8-K filed February 21, 2007 and Amendment #2 to the Amended and Restated Development and License Agreement filed as Exhibit 10.1 to a current Report on Form 8-K filed December 21, 2007.

About Palomar Medical Technologies, Inc.
Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the- counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets. In addition to the non- exclusive License Agreement with P&G, Palomar also has an agreement with Johnson & Johnson Consumer Companies to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne.

Palomar Medical Technologies, Inc.
781.993.2411
www.palomarmedical.com

Source: Palomar Medical Technologies, Inc.

Three New Aesthetic Products from Cynosure

- SmartSense(TM) for Smartlipo(TM): The World’s First Intelligent
Delivery System for Laser Lipolysis

- Accolade(TM): Cynosure’s Flagship Solution for the Removal of
Pigmented Lesions

- Affirm Er: An Ablative Energy Source that Expands the Affirm(TM)
Anti-Aging Workstation for Skin Resurfacing

Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, announced the introduction of three aesthetic products for fast-growing applications including laser lipolysis, the removal of pigmented lesions and ablative skin resurfacing. Cynosure will showcase its new products, SmartSense(TM) for Smartlipo(TM), Accolade(TM) and Affirm Er, at the American Academy of Dermatology (AAD) 2008 Annual Meeting, in San Antonio, Texas.

“Cynosure’s strategic vision is centered on the continuous improvement of aesthetic procedures through technology innovations that benefit patients and practitioners,” said Michael Davin, Cynosure’s president and chief executive officer. “Each of the products we are launching today fulfills that mission. Accolade, the sixth flagship product we have introduced in the past four years, creates exciting new revenue opportunities for us, particularly in markets throughout Asia, while SmartSense and Affirm Er enhance the benefits and performance of our two most recently introduced workstations.”

SmartSense for Smartlipo - Delivering Precise Energy Control to LaserBodySculpting
Recently FDA cleared, SmartSense is a proprietary intelligent handpiece delivery system for Smartlipo, Cynosure’s ground-breaking, minimally invasive system that liquefies and removes localized deposits of fat and results in tissue tightening through tissue coagulation. SmartSense features an advanced microchip, the Accelerometer, which is inserted into the intelligent handpiece, to ensure the precise level of energy is delivered based on the area of treatment and predetermined settings in conjunction with the motion of the handpiece.

“SmartSense provides our customers with an unparalleled degree of safety, precision and control that is not available with any other laser lipolysis technology,” Davin said. “Based on the setting you choose and the motion of the handpiece, SmartSense provides aesthetic surgeons with the precise laser power to perform laser lipolysis. To provide the maximum level of patient safety, if handpiece motion ceases SmartSense will stop the laser from firing, but remains ready and resumes firing once the handpiece is set in motion again.”

“SmartSense is an excellent addition to the Smartlipo workstation because it allows me to tailor the level of energy to the demands of the specific clinical indication,” said Barry Di Bernardo, M.D., medical director of New Jersey Plastic Surgery. “This not only helps to achieve a more consistent clinical outcome, but also adds an extra layer of safety and piece of mind for my patients. I look forward to incorporating the SmartSense into my laser lipolysis practice.”

Accolade - State-of-the-Art Technology to Remove Pigmented Lesions
Accolade is a high powered 755 nm, Q-switched Alexandrite laser for the removal of pigmented lesions. The unique combination of various spot sizes and the laser’s high repetition rates allow for rapid treatment. The initial target markets for Accolade will include Japan, Korea and China, where dermal lesions such as Nevus of Ota and Nevus of Ito are common.

“Given the market potential for this technology, particularly in the Asia Pacific region, we are excited about the prospects for Accolade,” Davin said. “As a flagship product, Accolade is expected to generate a minimum of $10 million in revenue in its first full year on the market.”

Affirm Er - Ablative Skin Resurfacing with Minimal Downtime
Cynosure’s new Affirm Er is a 2940 nm wavelength, Erbium: YAG laser for ablative skin resurfacing applications, such as the treatment of deep lines and wrinkles. The Affirm Er handpiece is designed as a complementary fourth wavelength for the Affirm Anti-Aging workstation, Cynosure’s award-winning platform for anti-aging applications such as skin rejuvenation, wrinkles, skin discoloration and tissue tightening.

“With the introduction of Affirm Er, we are responding to growing demand for an ablative technology that best addresses the treatment of deep lines and wrinkles,” Davin said. “Since its introduction a year ago, our innovative Affirm workstation has been enthusiastically received by the marketplace, both in the U.S. and overseas. By adding the Erbium wavelength, we are further increasing the versatility, flexibility and cost-effectiveness of Affirm for our customers.”

Bruce E. Katz, M.D., director of the Juva Skin & Laser Center, said, “For our patients, the Affirm system has been extremely effective in the treatment of wrinkles and scars, while tightening the underlying tissue. Some patients want a more rapid therapy for deep lines and wrinkles. The addition of this ablative component expands Affirm’s ability to address the anti-aging marketplace.”

According to the Millennium Research Group, the skin rejuvenation market is expected to grow annually by 18 percent, resulting in a $239 million industry by 2010, with approximately 4.4 million procedures performed per year by 2010.

About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure’s products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light.

Cynosure, Inc.
800.886.2966
www.cynosure.com

Source: Cynosure, Inc.

Candela Names Robert LaRoche Vice President of Global Marketing

WAYLAND, Mass.–(BUSINESS WIRE)–March 10, 2008–Candela Corporation (NASDAQ: CLZR) announced today that Robert LaRoche has joined the company as Vice President of Global Marketing. Mr. LaRoche will lead Candela’s worldwide marketing efforts of current products and pipeline product opportunities.

“With over 25 years of medical device marketing and sales experience, Bob is a proven leader in the medical device marketplace. We are confident that he will apply his unique skill set and insight to drive sales revenues and increase global awareness of Candela’s products,” said Jay Caplan, Chief Operating Officer.

Most recently, Mr. LaRoche served as Vice President of Marketing and Sales at InfraReDx, Inc., a Burlington, Massachusetts-based medical device start-up, where he led the marketing and sales development process for the company’s first commercialized product. Prior to that, he was Founder and President of Octant Marketing Inc., a consultancy serving the medical products industry, and has also held various managerial marketing positions.

Mr. LaRoche earned a Bachelor’s degree in Marine Fisheries Biology from the University of Massachusetts Amherst.

About Candela
Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 70 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 18 years ago, and currently has an installed base of an estimated 12,000 lasers worldwide.

Candela Corporation
800.733.8550
www.candelalaser.com

Source: Candela Corporation

Thermage, Inc. Announces Initial Shipments of Cellulite Product

HAYWARD, Calif., March 12 /PRNewswire-FirstCall/ — Thermage, Inc. (Nasdaq: THRM), a leader in non-invasive tissue tightening in the aesthetic industry, today announced it has begun initial shipments of its ThermaTip(TM) CL treatment tips for use in the Company’s cellulite procedure. The procedure noticeably reduces the appearance of cellulite after just a single treatment. The treatment tip and procedure are the result of 21 months of clinical and technological development and use the FDA cleared ThermaCool(R) system for the temporary improvement in the appearance of cellulite.

“We began shipments of our ThermaTip CL treatment tip on track and within the timeframe we expected,” said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. “Cellulite offers a new market opportunity for our Company and we expect the new tip to provide a solid contribution to our revenue in 2008.”

The ThermaTip CL and cellulite procedure by Thermage incorporate the Company’s patented monopolar capacitive radiofrequency technology. The advanced deep heating ThermaTip CL rebuilds collagen connective tissues and improves blood flow to the tissue helping to smooth the appearance of the skin’s surface.

About Thermage, Inc.
Thermage’s innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing “anti- aging” market.

Thermage, Inc.
510.259.7117
www.thermage.com

Source: Thermage, Inc.